NCT03279523View on ClinicalTrials.gov

F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

May 3, 2016

Primary Completion Date

May 23, 2018

Study Completion Date

May 23, 2018

Conditions
Alzheimer DiseaseHIV
Interventions
DRUG

F 18 T807

Participants will receive a single intravenous bolus injection of approximately 6.5-10mCi (240-370MBq) of F 18 T807. For those who cannot tolerate the full exam, participants will receive single intravenous bolus injection of approximately 6.5-10mCi (240-370MBq) of F 18 T807.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Tammie L. S. Benzinger, MD, PhD

OTHER

NCT03279523 - F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected | Biotech Hunter | Biotech Hunter